Drug Profile


Alternative Names: BN 52080

Latest Information Update: 30 Aug 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ipsen
  • Class Antidiarrhoeals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diarrhoea

Most Recent Events

  • 15 Oct 2003 Discontinued - Phase-II for Diarrhoea in France (unspecified route)
  • 31 May 2003 Beaufour-Ipsen is now called Ipsen
  • 15 Oct 1999 No-Development-Reported for Diarrhoea in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top